Skip to main content
TipRanks
Go Ultimate75% OFF

EcoSynthetix (0Y8) AI Stock Analysis

0 Followers
DE:0Y8

EcoSynthetix

(Stuttgart:0Y8)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Conservative balance sheetVery low leverage and a substantial equity base reduce solvency risk and give EcoSynthetix flexibility to absorb earnings volatility. This financial resilience can support continued product development and commercialization efforts while limiting dependence on external financing.
Negative Factors
Persistent unprofitabilityDespite narrower losses and improved operating cash flow, EcoSynthetix has not established sustained profitability or reliable self-funding. Continued negative operating results can constrain reinvestment capacity and make execution more dependent on its existing cash resources.

EcoSynthetix (0Y8) vs. iShares MSCI Germany ETF (EWG)

-80%-60%-40%-20%0%20%DE:0Y8-59.30%EWG+6.88%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 103.46M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-64.7
Beta (1Y)
0.32
Revenue Growth
-16.13%
EPS Growth
-28.91%
Country
Germany
Employees
28
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

EcoSynthetix Business Overview & Revenue Model

Company Description

EcoSynthetix Inc., established in Burlington, Canada, in 1996, operates as a renewable chemistry company. It focuses on developing and commercializing bio-based technologies that serve as sustainable alternatives to conventional synthetic, petrochemi...

EcoSynthetix Earnings Call Summary

Earnings Call Date:Nov 03, 2026(Q3-2026)|% Change Since:8.25%|Next Earnings Date:Mar 03, 2027
Earnings Call SentimentNegative

The call highlighted meaningful product validation, expanding distribution, new trials and a strong cash position, but these positives were outweighed by a 38% sales decline, sharply lower volumes from two concentrated strategic customers, weakened pulp-market economics, an uncertain recovery timeline and management's acknowledgement that current results are unacceptable.

Positive Updates

Adjusted EBITDA Near Breakeven Despite Sales Pressure
Adjusted EBITDA was essentially breakeven at $39,000 in Q3 2026, despite the 38% decline in sales.

Negative Updates

Sharp Sales Decline
Q3 2026 sales were $3.6 million, down 38% or $2.2 million from the same period in 2025. Management described the current results as unacceptable.

Company Guidance

Management said it does not expect an immediate change in market conditions, while the international retailer plans its own trials of the next-generation DuraBind product in the coming quarter and Dow is expected to launch another MaizeCare product next spring during personal care show season; SurfLock opportunities were described as a few hundred thousand dollars for a new tissue mill, a few million dollars for a packaging line, and in the tens of millions of dollars for a large pulp mill, with 2 additional pulp producers progressing toward mill trials over the next few months. A tissue mill represents an opportunity of about $200,000 to $300,000 annually, and some North American tissue, packaging and pulp programs could be real in 2027; the DuraBind change agenda represents approximately $60 million, and the Board committed up to CAD 500,000 to share purchases through the NCIB in Q4.

EcoSynthetix Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:0Y8 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
TSE:BOSTSE:BOS51NeutralCAD 177.70M-93.88-1.34%2.15%4.72%59.65%
TSE:NANOTSE:NANO45NeutralCAD 82.65M-4.98-81.75%――-42.93%
TSE:CNOTSE:CNO43NeutralCAD 19.64M-6.98-89.62%―-29.28%-95.12%
TSE:GMGTSE:GMG42NeutralCAD 247.48M-8.33-969.63%―224.03%-204.33%
TSE:SURETSE:SURE39UnderperformCAD 4.20M-4.20-24.00%――-904.55%

* Basic Materials Sector Average

Performance Comparison

0%100%200%DE:0Y8TSE:BOSTSE:CNOTSE:NANOTSE:GMGTSE:SUREDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:0Y8 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:0Y8EcoSynthetix Inc.1.05-1.51-58.98%
TSE:BOSAirboss of America6.522.2452.19%
TSE:CNOCalifornia Nanotechnologies0.410.0615.71%
TSE:NANONano One Materials0.69-0.93-57.41%
TSE:GMGGraphene Manufacturing Group Ltd1.830.7772.64%
TSE:SURESureNano Science Ltd0.10-0.05-33.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.